Bouwmeester T A, van de Velde L, Collard D, Delewi R, Lamers A B G N, Beijk M A M, de Winter R J, Zijlstra I A J, Vogt L, van den Born B J H
Department Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Department Interventional Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Physiol Rep. 2025 Sep;13(18):e70572. doi: 10.14814/phy2.70572.
Renal flow reserve (RFR) is a hemodynamic measure of renal microvascular function and may help identify patients with renal artery stenosis (RAS) who could benefit from revascularization. Reference ranges and clinical correlates of RFR in patients with and without RAS remain unknown. We analyzed intra-arterial renal flow velocity measurements from 76 participants with and without RAS, all with eGFR ≥30 mL/min/1.73m. Each underwent baseline and dopamine-induced hyperemic flow assessments using an intrarenal bolus of 30 μg/kg. RFR was defined as the ratio of mean hyperemic to baseline flow. Group differences were assessed using descriptive statistics and linear regression models adjusting for potential confounders. Median RFR was similar between participants with RAS (1.73, IQR 1.31-2.11) and those without (1.88, IQR 1.60-2.47). Lower RFR was associated with lower eGFR (p = 0.027). Higher RFR values were observed in participants using beta-blockers (p = 0.010), independent of age, sex, eGFR, and blood pressure. RFR was negatively associated with eGFR and positively with beta-blocker use. No associations were found with age, sex, hypertension, diabetes, or presence of RAS. The link with beta-blockers may be caused by interactions with the systemic and renal dopaminergic system.
肾血流储备(RFR)是一种评估肾微血管功能的血流动力学指标,可能有助于识别可从血管重建术中获益的肾动脉狭窄(RAS)患者。RAS患者和非RAS患者的RFR参考范围及临床相关性尚不清楚。我们分析了76名有或无RAS参与者的肾内动脉血流速度测量值,所有参与者的估算肾小球滤过率(eGFR)均≥30 mL/min/1.73m²。每位参与者均接受了基线和多巴胺诱导的充血血流评估,通过肾内推注30 μg/kg多巴胺来进行。RFR定义为平均充血血流与基线血流的比值。使用描述性统计和针对潜在混杂因素进行调整的线性回归模型评估组间差异。RAS参与者的RFR中位数(1.73,四分位间距1.31 - 2.11)与无RAS参与者的RFR中位数(1.88,四分位间距1.60 - 2.47)相似。较低的RFR与较低的eGFR相关(p = 0.027)。使用β受体阻滞剂的参与者观察到较高的RFR值(p = 0.010),且不受年龄、性别、eGFR和血压的影响。RFR与eGFR呈负相关,与β受体阻滞剂的使用呈正相关。未发现与年龄、性别、高血压、糖尿病或RAS的存在有关联。与β受体阻滞剂的关联可能是由与全身和肾多巴胺能系统的相互作用引起的。